Safety After Oral Intake
8
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Effects of Energy Drinks on Cardiovascular Endpoints
Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants
A Research Study to Evaluate BLX-7006 in Healthy Adults
Chrysin Bioavailability and Safety
Comparison of Curcumin Bioavailability
Oral Bioavailability and Bioactivity of Prenylflavonoids From Hops
Bioavailability of Resveratrol From Vineatrol30 Extract Incorporated Into Micelles
Absorption and Excretion Kinetics of the Bioactive Ingredients of Rice Bran Extract